Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Renovis
company
About
Renovis,is a biopharmaceutical company developing drugs to treat neurological diseases and disorders.
- 51 - 100
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $34.30M
- Industries
- Innovation Management,Medical,Professional Services
- Founded date
- Jan 1, 2000
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Renovis, Inc. is a biopharmaceutical company developing drugs to treat neurological diseases and disorders. The Company is currently developing products for acute ischemic stroke, for the treatment of neuropathic pain, and for the treatment of acute post-operative pain.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$34.30M
Renovis has raised a total of
$34.30M
in funding over 2 rounds. Their latest funding was raised on
Jan 10, 2002 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 10, 2002 | Series B | $34.30M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Renovis is funded by 1 investors.
International BM Biomedicine Holdings AG
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
